NWSA
45
2
BK
69
4
KHC
36
5
TROW
34
7
XOM
60
4
SCHW
40
7
HAL
60
3
SO
68
2
FITB
55
3
URI
62
2
MDLZ
30
2
OI
49
6
KMI
61
4
PHM
61
-3
ROK
43
3
PPG
60
4
DIS
52
4
JPM
66
9
PCAR
56
4
PWR
67
2
NWSA
45
2
BK
69
4
KHC
36
5
TROW
34
7
XOM
60
4
SCHW
40
7
HAL
60
3
SO
68
2
FITB
55
3
URI
62
2
MDLZ
30
2
OI
49
6
KMI
61
4
PHM
61
-3
ROK
43
3
PPG
60
4
DIS
52
4
JPM
66
9
PCAR
56
4
PWR
67
2
Financhill
Back

Assembly Biosciences 10K Form

Sell
22

ASMB
Assembly Biosciences

Last Price:
14.25
Seasonality Move:
0.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ASMB News And Ratings

See the #1 stock for the next 7 days that we like better than ASMB

ASMB Financial Statistics

Sales & Book Value

Annual Sales: $7.16M
Cash Flow: $-17.12M
Price / Cash Flow: 3.22
Annual Sales: $5.47
Price / Book: 2.73

Profitability

EPS (TTM): -8.62000
Net Income (TTM): $-45.61M
Gross Margin: $0
Return on Equity: -111.22%
Return on Assets: -46.52%

Assembly Biosciences Earnings Forecast

Key Assembly Biosciences Financial Ratios

  • The Selling, General & Administrative Expenses for ASMB have been equal to 319.82% of Gross Profit Margin.
  • The Research & Development expenses have been 682.67% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 11 years.

Assembly Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ASMB
CUSIP: 045396
Website: assemblybio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.74
Quick Ratio: 2.65

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ASMB Technical Analysis vs Fundamental Analysis

Sell
22
Assembly Biosciences (ASMB) is a Sell

Is Assembly Biosciences a Buy or a Sell?